Search the web
Welcome, Guest
[Sign Out, My Account]
EDGAR_Online

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
SUPN > SEC Filings for SUPN > Form 8-K on 21-Nov-2012All Recent SEC Filings

Show all filings for SUPERNUS PHARMACEUTICALS INC | Request a Trial to NEW EDGAR Online Pro

Form 8-K for SUPERNUS PHARMACEUTICALS INC


21-Nov-2012

Other Events, Financial Statements and Exhibits


Item 8.01 Other Events

On November 19, 2012, Supernus Pharmaceuticals, Inc. (the "Company") issued a press release announcing the receipt of confirmation from the Food and Drug Administration (the "FDA") that Oxtellar XR has been granted three years of market exclusivity. A copy of this press release is furnished as Exhibit 99.1 hereto and is incorporated herein by reference.

On November 20, 2012, Supernus Pharmaceuticals, Inc. (the "Company") issued a press release announcing the receipt of positive topline results from its Phase IIb study on SPN-810 for the treatment of impulsive aggression in ADHD patients. A copy of this press release is furnished as Exhibit 99.2 hereto and is incorporated herein by reference.



Item 9.01 Financial Statements and Exhibits

(d) The following documents are furnished as Exhibits pursuant to Item 8.01, hereof:

Exhibit 99.1 - Press Release dated November 19, 2012 of the Company regarding receipt of confirmation of marketing exclusivity from the FDA.

Exhibit 99.2 - Press Release dated November 20, 2012 of the Company regarding receipt of results from its Phase IIb study on SPN-810.


  Add SUPN to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for SUPN - All Recent SEC Filings
Sign Up for a Free Trial to the NEW EDGAR Online Pro
Detailed SEC, Financial, Ownership and Offering Data on over 12,000 U.S. Public Companies.
Actionable and easy-to-use with searching, alerting, downloading and more.
Request a Trial Sign Up Now


Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.